- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Comdisco wins ISO 9002 certification
Medical equipment reconditioner Comdisco Medical Exchange has received ISO 9002 certification. The Rosemont, IL, company claims that it is the first medical equipment reconditioner to receive the certificate.The ISO 9000 program is a series of five
Medical equipment reconditioner Comdisco Medical Exchange has received ISO 9002 certification. The Rosemont, IL, company claims that it is the first medical equipment reconditioner to receive the certificate.The ISO 9000 program is a series of five worldwide standardspublished in 1987 by the International Organization for Standardizationin Geneva, Switzerland. The standards are intended to ensure qualitymanagement and assurance, with the ISO 9002 standard governingquality assurance in production and installation.
Comdisco's receipt of ISO 9002 certification will help reassurepurchasers concerned about buying quality reconditioned equipment,according to Kenneth A. Halverson, president of Comdisco MedicalEquipment Group.
Comdisco reconditions medical imaging equipment acquired eitheron the open market or from the group's $400 million lease portfolio.The market for used equipment is experiencing annual growth inexcess of 10% and is expected to hit $240 million by 1997, accordingto the company.
New Study Assesses Benefits of High-Resolution Photon-Counting for Computed Tomography Angiography
October 10th 2024Researchers found that ultra-high resolution photon-counting significantly enhanced visualization of small vessels and facilitated improved reduction of blooming artifacts for head and neck computed tomography angiography (CTA) scans.
Multicenter Study Identifies Key Factors Associated with Mammogram-Occult Ipsilateral Breast Cancer
October 9th 2024A symptomatic first breast cancer diagnosis, prevailing breast density at a second breast cancer diagnosis and trabecular thickening on surveillance mammography were linked to mammogram-occult ipsilateral breast cancer, according to new research.
